Principal Scientist
Merck & Co, Inc.
Boston, Massachusetts
Pierre Daublain works as Principal Scientist in the Discovery Pharmaceutical Sciences group at Merck Research Laboratories in Boston where he primarily supports Oncology research programs. His areas of expertise include physicochemical characterization and early formulation development of drug candidates, as well as development of informatics tools to model oral absorption and influence molecular design.
Dr. Daublain received an engineer diploma from CPE Lyon (France) in 1999. He obtained his Ph.D. in the laboratory of Prof. Martin Newcomb at the University of Illinois in Chicago in 2004, and his research focused on kinetic and mechanistic model studies of coenzyme B12-dependent rearrangements. He later conducted a post-doctoral fellowship at Northwestern University in the laboratory of Prof. Frederick Lewis, where he investigated electron transfer processes in DNA responsible for UV-induced damage.
Throughout his graduate and post-graduate studies, Dr. Daublain published several papers in the field or physical organic chemistry and pharmaceutical sciences.
Disclosure information not submitted.
Monday, October 17, 2022
3:15 PM – 3:30 PM ET